Home News Business Pharmactive Biotech CEO Nominated for the “Top 100 CEOs In Innovation Award...

Pharmactive Biotech CEO Nominated for the “Top 100 CEOs In Innovation Award 2021”

Jean-Marie Raymond, CEO of Pharmactive Biotech Products, has been chosen by the World Biz Magazine’s Annual Awards to receive the Top 100 CEOs In Innovation Award 2021. World Biz Magazine (WBM) has been awarding business leaders across the globe, making significant strides in their industries. Out of 40,000 leaders, Raymond is among the 100 shortlisted by WBM researchers and independent judges to receive the distinction.

Jean-Marie Raymond is a passionate entrepreneur with a clear vision to reveal the healing power of botanicals by applying breakthrough green technology backed by science. He completed his education in Marketing and Information Technology in France, England, and Spain. He subsequently obtained an Executive MBA at the institute de Empresas in Madrid. His professional career comprises about twenty years in the field of botanical and natural ingredients for food supplements. 

In 2009, Raymond founded Pharmactive Biotech that used saffron to produce its ingredients. The company established high-quality standards and continuous R&D investment as its core values. Pharmactive later became the first company to introduce saffron extract in the market for mood improvement. According to Julia Diaz, Head of Marketing at Pharmactive, Jean-Marie Raymond is a natural leader with a clear vision and knows how to motivate his team and get the best out of everyone.

Raymond has been described as a visionary in the field of botanicals. He has been able to introduce ancient ingredients such as affron, a saffron extract of premium quality, and ABG +, aged black garlic extract. His ability to apply eco-friendly practices to obtain the best purity and concentration can only be regarded as remarkable. By noticing the therapeutic power of plants, Jean-Marie Raymond has designed an eco-friendly extraction process.

 Since its inception, Pharmactive has undergone continuous growth. However, the organization’s development has significantly accelerated since 2017. The company has doubled the number of employees and has recorded an average annual sales growth greater than 23%. This successful outcome has been attributed to Pharmactive’s premium products; saffron extract and ABG+.

In July 2021, Private Equity Group Siparex, Paris, took a minority stake in Pharmactive. This transaction allows Pharmactive to accelerate its development plans through external growth and expand its portfolio of natural ingredients. “Positioned in a booming market, Pharmactive is an innovative company that an experienced and enthusiastic founding manager leads,” said Pierre Bordeaux Montrieux, Managing Director of Siparex Midcap. 

- Advertisment -

Most Popular

Allmicroalgae: Ancient Superfood Meets Modern-Day Demand

Allmicroalgae will introduce its portfolio of nutrient-rich, sustainable, and vegan-friendly microalgae ingredients at the Vitafoods expo. The company will showcase its new...
Read more

Exclusive Interview With Open Book Extracts CIO, Nicole Brown

As a Harvard University graduate, what got you interested in the nutraceutical and CBD industries?I was pre-med when I studied at Harvard....

NXT USA Unveils Novel, Clinically Validated Joint Health Ingredient

NXT USA, a new organization developing unique nutraceutical solutions, has launched a joint health product. TamaFlex, unveiled in 2020, provides flexibility, comfort,...

MasterControl Unveils the Latest Version of its Software and the Beginning of a New Beta Program

MasterControl, a global developer of software solutions for life sciences and other regulated industries, recently announced the newest...

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

- Advertisment -